Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
- PMID: 20020443
- DOI: 10.1002/jcp.21995
Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
Abstract
Despite advances in medical and surgical care, current clinical therapies for spinal cord injury (SCI) are limited. During the last two decades, the search for new therapies has been revolutionized by the discovery of stem cells, inspiring scientists and clinicians to search for stem cell-based reparative approaches for many disorders, including neurotrauma. Cell-based therapies using embryonic and adult stem cells in animal models of these disorders have provided positive outcome results. However, the availability of clinically suitable cell sources for human application has been hindered by both technical and ethical issues. The recent discovery of induced pluripotent stem (iPS) cells holds the potential to revolutionize the field of regenerative medicine by offering the option of autologous transplantation, thus eliminating the issue of host rejection. Herein, we will provide the rationale for the use of iPS cells in SCI therapies. In this review, we will evaluate the recent advancements in the field of iPS cells including their capacity for differentiation toward neural lineages that may allow iPS cells transplantation in cell-based therapy for spinal cord repair.
Similar articles
-
Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?Stem Cells. 2010 Jan;28(1):93-9. doi: 10.1002/stem.253. Stem Cells. 2010. PMID: 19904738 Review.
-
Neural stem cells in regenerative medicine: bridging the gap.Panminerva Med. 2010 Jun;52(2):125-47. Panminerva Med. 2010. PMID: 20517196 Review.
-
Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat.Acta Neurochir (Wien). 2005 Sep;147(9):985-92; discussion 992. doi: 10.1007/s00701-005-0538-y. Epub 2005 Jul 11. Acta Neurochir (Wien). 2005. PMID: 16010451
-
Transplantation tolerance in an age of induced pluripotency.Curr Opin Organ Transplant. 2009 Aug;14(4):321-5. doi: 10.1097/MOT.0b013e32832e9424. Curr Opin Organ Transplant. 2009. PMID: 19542888 Review.
-
Induced pluripotent stem cells: current progress and potential for regenerative medicine.Trends Mol Med. 2009 Feb;15(2):59-68. doi: 10.1016/j.molmed.2008.12.003. Epub 2009 Jan 21. Trends Mol Med. 2009. PMID: 19162546 Review.
Cited by
-
Development of new technologies for stem cell research.J Biomed Biotechnol. 2012;2012:741416. doi: 10.1155/2012/741416. Epub 2012 Nov 26. J Biomed Biotechnol. 2012. PMID: 23251081 Free PMC article. Review.
-
Clinical and experimental advances in regeneration of spinal cord injury.J Tissue Eng. 2010 Nov 2;2010:650857. doi: 10.4061/2010/650857. J Tissue Eng. 2010. PMID: 21350645 Free PMC article.
-
Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum.Stem Cells. 2010 Oct;28(10):1839-47. doi: 10.1002/stem.509. Stem Cells. 2010. PMID: 20799335 Free PMC article.
-
Patient-specific pluripotent stem cells in neurological diseases.Stem Cells Int. 2011;2011:212487. doi: 10.4061/2011/212487. Epub 2011 Jul 3. Stem Cells Int. 2011. PMID: 21776279 Free PMC article.
-
Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat.Stem Cell Res Ther. 2021 Oct 21;12(1):549. doi: 10.1186/s13287-021-02615-z. Stem Cell Res Ther. 2021. PMID: 34674761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical